Edition:
United Kingdom

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

559.75INR
13 Jul 2018
Change (% chg)

Rs-4.70 (-0.83%)
Prev Close
Rs564.45
Open
Rs566.80
Day's High
Rs567.00
Day's Low
Rs557.05
Volume
2,012,823
Avg. Vol
5,914,435
52-wk High
Rs608.95
52-wk Low
Rs432.70

Latest Key Developments (Source: Significant Developments)

Beijing Science Sun Pharmaceutical sees FY 2018 H1 net profit up 5 pct to 35 pct
Friday, 13 Jul 2018 

July 13(Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ> : :Sees FY 2018 H1 net profit to increase by 5 percent to 35 percent, or to be 110.6 million yuan to 142.2 million yuan.Says FY 2017 H1 net profit was 105.3 million yuan.The reasons for the forecast are improved marketing promotion and enhanced internal management .  Full Article

Sun Pharmaceutical Unit Files Lawsuit Against Biofrontera For Patent Infringement
Wednesday, 11 Jul 2018 

July 11 (Reuters) - Biofrontera AG ::SUN PHARMACEUTICAL INDUSTRIES LTD - CO'S UNIT, DUSA PHARMACEUTICALS FILES LAWSUIT AGAINST BIOFRONTERA FOR PATENT INFRINGEMENT.SUN PHARMACEUTICAL INDUSTRIES - LAWSUIT ALLEGES PATENT INFRINGEMENT OF DUSA'S PATENTS, US 9,723,991 AND US 8,216,289.  Full Article

US FDA Says Issues Voluntary Action Indicated Status To India's Sun Pharma On Halol Drug Plant
Friday, 8 Jun 2018 

June 8 (Reuters) - Sun Pharmaceutical Industries Ltd ::US FDA SAYS ISSUES VOLUNTARY ACTION INDICATED STATUS TO INDIA'S SUN PHARMA ON HALOL DRUG PLANT.  Full Article

Sun Pharmaceutical Industries' Units Gets Approval For Yonsa
Wednesday, 23 May 2018 

May 23 (Reuters) - Sun Pharmaceutical Industries Ltd ::U.S.FDA APPROVAL OF YONSA.ONE OF CO'S WHOLLY OWNED UNITS GOT APPROVAL FOR YONSA.CHURCHILL PHARMACEUTICALS, ELIGIBLE TO GET UPFRONT AND SALES-LINKED MILESTONE PAYMENT AND ROYALTIES ON SALES FROM CO.  Full Article

Perrigo Confirms First To File Patent Challenge For Generic Ultravate Lotion
Monday, 14 May 2018 

May 14 (Reuters) - Perrigo Company PLC ::PERRIGO CONFIRMS FIRST TO FILE PATENT CHALLENGE FOR GENERIC VERSION OF ULTRAVATE LOTION, 0.05%.PERRIGO COMPANY PLC - SUN PHARMACEUTICAL INDUSTRIES & MICAL PHARMACEUTICALS INITIATED PATENT LITIGATIONS ON MAY 9 & 10, 2018.PERRIGO COMPANY PLC - LITIGATIONS REGARDING PARAGRAPH IV ABBREVIATED NDA FOR HALOBETASOL PROPIONATE LOTION, 0.05%.  Full Article

Sun Pharmaceutical Industries' Unit Raises Stake In Ranbaxy Malaysia
Wednesday, 18 Apr 2018 

April 18 (Reuters) - Sun Pharmaceutical Industries Ltd ::UNIT RAISED STAKE IN RANBAXY MALAYSIA VIA FURTHER PURCHASE OF 394,404 SHARES OF RANBAXY MALAYSIA.SAYS POST SHARE PURCHASE, CO'S TOTAL HOLDING IN RANBAXY MALAYSIA WIL INCREASE FROM 90.74 PCT TO 95.67 PCT.  Full Article

Beijing Science Sun Pharmaceutical sees FY 2017 net profit to down 15 pct to up 15 pct
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>:Says it sees FY 2017 net profit to decrease by 15 percent to increase by 15 percent, or to be 219.6 million yuan to 297.2 million yuan.Says FY 2016 net profit was 258.4 million yuan.Comments that expanded market and decreased costs as main reasons for the forecast .  Full Article

Sun Pharmaceutical Industries Announces Settlement Of Patent Litigation For Generic Linzess In U.S.
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS CO'S UNITS HAVE REACHED AN AGREEMENT WITH IRONWOOD PHARMACEUTICALS, INC. AND ALLERGAN PLC.ANNOUNCES SETTLEMENT OF PATENT LITIGATION FOR GENERIC LINZES IN US.COMPANIES TO GRANT CO'S UNITS LICENSE TO MARKET GENERIC VERSION OF LINZESS IN U.S FROM FEB 1, 2031 OR EARLIER UNDER CIRCUMSTANCES.ADDITIONAL DETAILS REGARDING THE SETTLEMENT WERE NOT DISCLOSED..  Full Article

Allergan, Ironwood Announce Settlement With Sun Pharma
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Allergan Plc ::IRONWOOD AND ALLERGAN ANNOUNCE SETTLEMENT WITH SUN PHARMA RESOLVING LINZESS® (LINACLOTIDE) PATENT LITIGATION.SAYS PER SETTLEMENT TERMS, IRONWOOD, CO TO GRANT UNITS OF SUN PHARMA LICENSE TO MARKET GENERIC VERSION OF LINZESS IN U.S. BEGINNING FEB 1, 2031​.SAYS ‍ADDITIONAL DETAILS REGARDING SETTLEMENT WERE NOT DISCLOSED​.SAYS IRONWOOD PHARMACEUTICALS, CO ANNOUNCED COMPANIES REACHED AN AGREEMENT WITH WHOLLY-OWNED UNITS OF SUN PHARMACEUTICAL INDUSTRIES.SAYS ‍AS A RESULT OF SETTLEMENT, ALL HATCH-WAXMAN LITIGATION BETWEEN COMPANIES AND SUN PHARMA REGARDING LINZESS PATENTS TO BE DISMISSED​.  Full Article

Sun Pharmaceutical Industries Announces U.S FDA Acceptance Of NDA For OTX-101
Wednesday, 27 Dec 2017 

Dec 27 (Reuters) - Sun Pharmaceutical Industries Ltd ::ANNOUNCES U.S FDA ACCEPTANCE OF NDA FOR OTX-101.  Full Article

Photo

Exclusive - With U.S. trade under a cloud, China opens to Indian pharma

NEW DELHI China is preparing to give swift regulatory approvals to India-manufactured drugs, the head of an Indian export promotion group said, as Beijing looks for new commercial partners ahead of what could be a protracted trade war with the United States.